Increasing Prevalance Of Hypoglycemia Increase The Dextrose Injection Demand
Dextrose Injections USP are sterile, nonpyrogenic, and contain no bacteriostatic or antimicrobial agents. These products are intended for intravenous administration. Dosage of dextrose injection is dependent upon the age, weight, and clinical condition of the patient as well as laboratory determinations.
Weifang Shengtai supplied Kelun Pharmaceutical which has grown into a pharmaceutical group with 16 subsidiaries with 10 thousand tons of dextrose monohydrate injection grade.
In 2018, SteriMAx Inc., engaged in production, development, marketing, and distribution of essential hospital and retail pharmacy products, launched new drug Bupivacaine Hydrochloride in 8.25% dextrose injection indicated for spinal anesthesia. It is a subarachnoid injection (spinal block).
Increasing the prevalence of diseases such as hypoglycemia is expected to increase the demand for dextrose injection, which in turn is expected to fuel market growth. According to a survey conducted by the Center for Disease Prevention and Control (CDC), in 2016, more than 1.5 million people in the U.S. have hypoglycemia.
Even the most effective – and draconian – containment strategies have only slowed the spread of the respiratory disease COVID-19. When the World Health Organization finally declares a COVID-19 a pandemic, all eyes have turned to the prospect of a vaccine, because only a vaccine can prevent people from getting sick.
About 35 companies and academic institutions are racing to create such a vaccine, at least four of which already have candidates they have been testing in animals. The first of these – produced by Boston-based biotech firm Moderna – will enter human trials imminently.
Creating a safe vaccine for a new illness is no easy feat. Thankfully, rapid progress is being made for a variety of reasons, including China’s efforts to sequence the genetic material of Sars-CoV-2 and to share that information with research groups around the world. Another factor contributing to the unprecedented speed of development is the fact that coronaviruses were already on the radar of health science researchers. Both SARS and MERS were caused by coronaviruses, and even though vaccines were shelved once those outbreaks were contained, learnings can still be applied to defeating COVID-19.
One of the most promising leads on a COVID-19 vaccine is mRNA-1273. This vaccine, developed by Moderna Therapeutics, is being developed with extreme urgency, skipping straight into human trials before it was even tested in animals. If all goes well with the trials currently underway in Washington State, the company hopes to have an early version of the vaccine ready by fall 2020.
Further down the pipeline are 15 types of subunit vaccines. This method of vaccination uses a fragment of a pathogen, typically a surface protein, to trigger an immune response, teaching the body’s immune system how to fight off the disease without actually introducing live pathogens.
Global Dextrose Injection Market Landscape
Goldstein Research analyst forecasts the dextrose injection market size is set to register the growing CAGR of 5.2% over the forecast years (2017-2030).
Based on product type, 5% dextrose injection held the largest share valued 42% in the global dextrose injection market owing to the increasing usage in clinical pharmacology where dextrose and sodium chloride injection.
Based on geography, APAC held the dominant position in global dextrose injection market with the market share of 40% in 2017 owing to the presence of leading producer like Weifang Shengtai of pharmaceutical injection-grade glucose in China, which has about 40% of the market and is one of the only 3 licensed manufacturers in China of injection grade dextrose monohydrate.
Companies covered in the Global Dextrose Injection Market:
- Pfizer
- Amphastar
- ChanGee
- HAIXIN
- Seqirus
- Baxter
- Shandong Qidu Pharmaceutical
- Sanctus Drugs & Pharmaceuticals Pvt.
- Mountainside Medical
- Shaanxi Torch Biotechnology
- Hospira
- B Braun
- Shangai Haixin group Co. Ltd.
- Aurobindo Pharmaceuticals Ltd.
- SteriMAx Inc.
- ChanGee
- HAIXIN
Scope of The Report
- Helps the reader to understand the country-specific landscape in the Global Dextrose Injection, the recent trends, and challenges. Moreover, the report also outlines enterprises' investment priorities in the healthcare sector
- Provides the Market Size (USD Billion), Market Share (%), CAGR (%), Y-O-Y Growth Rate (%) of Global Dextrose Injection Market and further bifurcated into Regions & Countries.
- The study provides an in-depth analysis of current and future trends to elucidate the imminent investment pockets in the market.
- Impact Analysis of COVID-19 on Global Dextrose Injection Market.
- Detailed Analysis of a group of health start-ups in the burgeoning Global Dextrose Injection space
- List of new partnerships that supplementing existing service with the new service.
- Market analysis on validation, exit strategies, future of Global Dextrose Injection
- The report provides a detailed description of the future outlook of Global Dextrose Injection which is the next focus area in the healthcare industry.
- Give the roadmap to the Global Dextrose Injection market and explains how companies developing diabetic drug alternatives are transforming healthcare and identifies the key operating players
- Helps the client to explore how Global Dextrose Injection stands to benefit and threaten entrenched players.
- The most exhaustive and up-to-date report providing revenue opportunity forecasts in the Global Dextrose Injection market from 2017 to 2030, spanning various sub-segments, 6 regions, and 195 countries, and investment priorities.
Global Dextrose Injection Market Segmentation
By Product Type
- 5% Dextrose Injection
- 10% Dextrose Injection
- 50% Dextrose Injection
- 70% Dextrose Injection
- Other
By Application
- Sports
- First-Aid Treatment
- Trophotherapy
- Other
By End-User
- Hospital
- Medical Center
- Others
Based on Geography
- North America (U.S. & Canada) Dextrose injection Market {Market Share (%), Market Size (USD Billion)}
- Latin America (Brazil, Mexico, Argentina & Rest of Latin America) Dextrose injection Market {Market Share (%), Market Size (USD Billion)}
- Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) Dextrose injection Market {Market Share (%), Market Size (USD Billion)}
- Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) Dextrose injection Market {Market Share (%), Market Size (USD Billion)}
- Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Dextrose injection Market {Market Share (%), Market Size (USD Billion)}